ROKIT Healthcare Inc. (KOSDAQ:376900)
South Korea · Delayed Price · Currency is KRW 91,200
-2,000 (-2.15%)
At close: Apr 10, 2026
ROKIT Healthcare Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 26,247 | 13,111 | 12,418 | 9,151 | 6,741 |
Other Revenue | -0 | -0 | -0 | -0 | - |
| 26,247 | 13,111 | 12,418 | 9,151 | 6,741 | |
Revenue Growth (YoY) | 100.19% | 5.59% | 35.70% | 35.76% | 68.94% |
Cost of Revenue | 10,577 | 7,147 | 8,391 | 6,087 | 5,126 |
Gross Profit | 15,670 | 5,964 | 4,026 | 3,064 | 1,615 |
Selling, General & Admin | 12,994 | 8,217 | 8,353 | 12,747 | 13,661 |
Research & Development | 1,023 | 1,571 | 1,772 | 2,979 | 3,825 |
Amortization of Goodwill & Intangibles | 315.64 | 304.26 | 465.35 | 433.47 | 448.22 |
Other Operating Expenses | 42.1 | 31.03 | 46.03 | 46 | 51.68 |
Operating Expenses | 15,634 | 12,006 | 11,594 | 16,938 | 18,935 |
Operating Income | 35.58 | -6,042 | -7,568 | -13,873 | -17,320 |
Interest Expense | -4,570 | -6,845 | -6,209 | -4,503 | -3,290 |
Interest & Investment Income | 380.67 | 51.64 | 50.57 | 30.08 | 29.52 |
Earnings From Equity Investments | -2.99 | - | - | - | - |
Currency Exchange Gain (Loss) | 9.85 | -53.56 | 19.13 | 21.99 | 285.9 |
Other Non Operating Income (Expenses) | 2,182 | 5,533 | 31,218 | 20,353 | -35,526 |
EBT Excluding Unusual Items | -1,965 | -7,356 | 17,511 | 2,029 | -55,820 |
Gain (Loss) on Sale of Assets | 0.86 | 0.99 | -2.29 | -1.8 | 0.36 |
Asset Writedown | 44.29 | 18.28 | -687.74 | - | -464.33 |
Other Unusual Items | - | - | 10.11 | - | - |
Pretax Income | -1,920 | -7,337 | 16,831 | 2,027 | -56,284 |
Income Tax Expense | 885.21 | 352.74 | 204.02 | 169.59 | 108.86 |
Earnings From Continuing Operations | -2,805 | -7,690 | 16,627 | 1,857 | -56,393 |
Minority Interest in Earnings | -40.46 | 44.34 | -27.17 | 17.39 | 145.59 |
Net Income | -2,845 | -7,646 | 16,600 | 1,875 | -56,247 |
Net Income to Common | -2,845 | -7,646 | 16,600 | 1,875 | -56,247 |
Net Income Growth | - | - | 785.55% | - | - |
Shares Outstanding (Basic) | 13 | 8 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 13 | 8 | 12 | 12 | 7 |
Shares Change (YoY) | 63.94% | -34.18% | 0.64% | 72.42% | 6.78% |
EPS (Basic) | -222.00 | -978.00 | 2324.34 | 267.01 | -8217.71 |
EPS (Diluted) | -222.00 | -978.00 | -829.59 | -1232.84 | -8218.00 |
Free Cash Flow | -17,393 | -5,023 | -4,065 | -6,777 | -12,121 |
Free Cash Flow Per Share | -1357.11 | -642.48 | -342.24 | -574.26 | -1770.81 |
Gross Margin | 59.70% | 45.49% | 32.42% | 33.49% | 23.96% |
Operating Margin | 0.14% | -46.09% | -60.94% | -151.61% | -256.95% |
Profit Margin | -10.84% | -58.31% | 133.68% | 20.48% | -834.44% |
Free Cash Flow Margin | -66.27% | -38.31% | -32.73% | -74.06% | -179.81% |
EBITDA | 835.61 | -5,054 | -6,300 | -12,498 | -15,712 |
EBITDA Margin | 3.18% | -38.55% | -50.73% | -136.57% | -233.08% |
D&A For EBITDA | 800.03 | 987.8 | 1,267 | 1,376 | 1,609 |
EBIT | 35.58 | -6,042 | -7,568 | -13,873 | -17,320 |
EBIT Margin | 0.14% | -46.08% | -60.94% | -151.61% | -256.95% |
Effective Tax Rate | - | - | 1.21% | 8.37% | - |
Advertising Expenses | 1,875 | 430.02 | 303.4 | 752.62 | 647.84 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.